Suzetrigine

Brand name: Journavx

E

Score E — Unlikely Hepatotoxin

Despite extensive use, there is no convincing evidence that this drug causes liver injury.

Single case reports may have been published, but they were largely unconvincing. The agent is not believed or is unlikely to cause liver injury.

Primary class Analgesic
Secondary class Mod-Severe Pain
FDA approval 2025